• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 活动风险计算器:一种游戏化的公共卫生干预工具。

COVID-19 activity risk calculator as a gamified public health intervention tool.

机构信息

Department of Neurosciences, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Academics for the Future of Science Inc., Cambridge, MA, USA.

出版信息

Sci Rep. 2023 Aug 11;13(1):13056. doi: 10.1038/s41598-023-40338-8.

DOI:10.1038/s41598-023-40338-8
PMID:37567913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10421890/
Abstract

The Coronavirus disease 2019 (COVID-19) pandemic, caused by the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has impacted over 200 countries leading to hospitalizations and deaths of millions of people. Public health interventions, such as risk estimators, can reduce the spread of pandemics and epidemics through influencing behavior, which impacts risk of exposure and infection. Current publicly available COVID-19 risk estimation tools have had variable effectiveness during the pandemic due to their dependency on rapidly evolving factors such as community transmission levels and variants. There has also been confusion surrounding certain personal protective strategies such as risk reduction by mask-wearing and vaccination. In order to create a simple easy-to-use tool for estimating different individual risks associated with carrying out daily-life activity, we developed COVID-19 Activity Risk Calculator (CovARC). CovARC is a gamified public health intervention as users can "play with" how different risks associated with COVID-19 can change depending on several different factors when carrying out routine daily activities. Empowering the public to make informed, data-driven decisions about safely engaging in activities may help to reduce COVID-19 levels in the community. In this study, we demonstrate a streamlined, scalable and accurate COVID-19 risk calculation system. Our study also demonstrates the quantitative impact of vaccination and mask-wearing during periods of high case counts. Validation of this impact could inform and support policy decisions regarding case thresholds for mask mandates, and other public health interventions.

摘要

新型冠状病毒病 2019(COVID-19)大流行是由病毒严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的,已经影响了 200 多个国家,导致数百万人住院和死亡。公共卫生干预措施,如风险评估器,可以通过影响行为来减少大流行和传染病的传播,从而影响暴露和感染的风险。由于依赖于社区传播水平和变体等快速演变的因素,当前公共可用的 COVID-19 风险估计工具在大流行期间的效果各不相同。围绕某些个人防护策略也存在困惑,例如戴口罩和接种疫苗可降低风险。为了创建一个简单易用的工具来估计与进行日常活动相关的不同个体风险,我们开发了 COVID-19 活动风险计算器(CovARC)。CovARC 是一种游戏化的公共卫生干预措施,因为用户可以在进行日常活动时“玩”不同的 COVID-19 风险如何因几种不同因素而变化。让公众能够就安全参与活动做出明智的、基于数据的决策,可能有助于降低社区中的 COVID-19 水平。在这项研究中,我们展示了一个简化、可扩展和准确的 COVID-19 风险计算系统。我们的研究还表明了在高病例数期间接种疫苗和戴口罩的定量影响。这种影响的验证可以为有关口罩强制令和其他公共卫生干预措施的病例阈值的政策决策提供信息和支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0620/10421890/e4a9e7b2491c/41598_2023_40338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0620/10421890/b8a1cb61f43a/41598_2023_40338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0620/10421890/9fe8b43b06fd/41598_2023_40338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0620/10421890/e4a9e7b2491c/41598_2023_40338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0620/10421890/b8a1cb61f43a/41598_2023_40338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0620/10421890/9fe8b43b06fd/41598_2023_40338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0620/10421890/e4a9e7b2491c/41598_2023_40338_Fig3_HTML.jpg

相似文献

1
COVID-19 activity risk calculator as a gamified public health intervention tool.COVID-19 活动风险计算器:一种游戏化的公共卫生干预工具。
Sci Rep. 2023 Aug 11;13(1):13056. doi: 10.1038/s41598-023-40338-8.
2
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
3
Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study.戴口罩与美国 SARS-CoV-2 传播的控制:一项横断面研究。
Lancet Digit Health. 2021 Mar;3(3):e148-e157. doi: 10.1016/S2589-7500(20)30293-4. Epub 2021 Jan 19.
4
Nonpharmaceutical public health interventions to curb the COVID-19 pandemic: a narrative review.非药物公共卫生干预措施以遏制 COVID-19 大流行:叙述性评论。
J Infect Dev Ctries. 2022 Apr 30;16(4):583-591. doi: 10.3855/jidc.14580.
5
Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.单独隔离或与其他公共卫生措施相结合以控制新冠病毒病:一项快速综述
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013574. doi: 10.1002/14651858.CD013574.pub2.
6
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics.公众对控制 SARS-CoV-2 大流行的非药物干预措施的偏好:公共卫生、个人权利和经济学之间的权衡。
Eur J Health Econ. 2022 Dec;23(9):1483-1496. doi: 10.1007/s10198-022-01438-w. Epub 2022 Feb 9.
7
Mask or no mask for COVID-19: A public health and market study.口罩还是不戴口罩:一项关于 COVID-19 的公共卫生和市场研究。
PLoS One. 2020 Aug 14;15(8):e0237691. doi: 10.1371/journal.pone.0237691. eCollection 2020.
8
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
9
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.在丹麦口罩佩戴者中,将口罩推荐与其他公共卫生措施结合使用以预防 SARS-CoV-2 感染的效果:一项随机对照试验。
Ann Intern Med. 2021 Mar;174(3):335-343. doi: 10.7326/M20-6817. Epub 2020 Nov 18.
10
Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.中亚地区 SARS-CoV-2 传播的监测指标:纵向趋势分析。
J Med Internet Res. 2021 Feb 3;23(2):e25799. doi: 10.2196/25799.

本文引用的文献

1
Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) variants.住院 COVID-19 患者在 SARS-CoV-2 阿尔法(B.1.1.7)和德尔塔(B.1.617.2)变异株流行期间的死亡率。
Sci Rep. 2022 Nov 7;12(1):18918. doi: 10.1038/s41598-022-23312-8.
2
Evaluation of risk factors associated with SARS-CoV-2 transmission.评估与 SARS-CoV-2 传播相关的危险因素。
Curr Med Res Opin. 2022 Dec;38(12):2021-2028. doi: 10.1080/03007995.2022.2125258. Epub 2022 Oct 14.
3
Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants.
新冠病毒 Alpha 和 Delta 变异株流行期间病例严重程度。
Sci Rep. 2022 Sep 14;12(1):15456. doi: 10.1038/s41598-022-19125-4.
4
Symptoms and risk factors for long COVID in non-hospitalized adults.非住院成年人的长新冠症状和风险因素。
Nat Med. 2022 Aug;28(8):1706-1714. doi: 10.1038/s41591-022-01909-w. Epub 2022 Jul 25.
5
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.与非 AY.4.2 德尔塔变异亚系相比,感染 SARS-CoV-2 AY.4.2(VUI-21OCT-01)的 COVID-19 病例的住院和死亡风险。
J Infect Dis. 2022 Sep 13;226(5):808-811. doi: 10.1093/infdis/jiac063.
6
SARS-CoV-2 E484K Mutation Narrative Review: Epidemiology, Immune Escape, Clinical Implications, and Future Considerations.严重急性呼吸综合征冠状病毒2型E484K突变综述:流行病学、免疫逃逸、临床意义及未来考量
Infect Drug Resist. 2022 Feb 3;15:373-385. doi: 10.2147/IDR.S344099. eCollection 2022.
7
Global monitoring of the impact of the COVID-19 pandemic through online surveys sampled from the Facebook user base.通过从 Facebook 用户基础中抽取的在线调查对 COVID-19 大流行的影响进行全球监测。
Proc Natl Acad Sci U S A. 2021 Dec 21;118(51). doi: 10.1073/pnas.2111455118.
8
Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database.分析从 GISAID 数据库中检索到的 329,942 份 SARS-CoV-2 记录。
Comput Biol Med. 2021 Dec;139:104981. doi: 10.1016/j.compbiomed.2021.104981. Epub 2021 Oct 26.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.辉瑞-BioNTech 信使核糖核酸新冠病毒疫苗 6 个月的安全性和有效性
N Engl J Med. 2021 Nov 4;385(19):1761-1773. doi: 10.1056/NEJMoa2110345. Epub 2021 Sep 15.
10
Is 14-Days a Sensible Quarantine Length for COVID-19? Examinations of Some Associated Issues with a Case Study of COVID-19 Incubation Times.14天对新冠病毒来说是合理的隔离时长吗?结合新冠病毒潜伏期的案例研究对一些相关问题的探讨
Stat Biosci. 2022;14(1):175-190. doi: 10.1007/s12561-021-09320-8. Epub 2021 Sep 9.